BioCentury | May 26, 2017
Finance

Europe’s bellwether challenge

...The other two were British Biotech plc , which infamously imploded in 1998, and Celltech Group plc...
...in 2006 • Lack of internal R&D • Distraction by patent battle with MorphoSys AG Celltech Group plc...
BioCentury | Jul 21, 2016
Strategy

Brexit of brains

...but were taken out via M&A, blunting the growth of the ecosystem. Most notable were Celltech Group plc...
BioCentury | Jun 27, 2016
Finance

Nine lives?

...the funk lasted for at least five years. The next heir to the throne was Celltech Group plc...
BioCentury | Dec 24, 2012
Strategy

The deCoding of Amgen

...bone mineral density was associated with a loss-of-function mutation in the sclerostin gene. In 2002, Celltech Group plc...
BioCentury | Dec 2, 2011
Politics & Policy

EU court ruling clarifies SPCs for combo products

...supporting marketing authorization covered a product with nine ingredients. Medeva was acquired in 2000 by Celltech Group...
BioCentury | Jan 10, 2011
Company News

Symphogen board of directors update

...Symphogen A/S , Copenhagen, Denmark Business: Antibodies Appointed: Goran Ando as chairman, previously CEO of Celltech Group plc...
BioCentury | Jan 7, 2011
Top Story

Symphogen raises EUR 100 million

...also participated. Symphogen also appointed Goran Ando as chairman. Ando is the former CEO of Celltech Group plc...
BioCentury | Dec 20, 2010
Strategy

TAP's Big Finish

...up front from adding additional antigens Up to $1.4B under Aug 2010 amended deal 2002 Celltech Group plc...
BioCentury | Mar 8, 2010
Strategy

Merck's Chemical Test

...UCB started the trend in 2004 when it sold off its chemicals business and acquired Celltech Group plc...
BioCentury | Jan 11, 2010
Strategy

Evolution of Biogen Idec's Pipeline

...CDP 571 humanized anti-TNF alpha mAb Crohn's disease Dropped Partnered by Biogen in 2002 from Celltech Group plc...
Items per page:
1 - 10 of 290
BioCentury | May 26, 2017
Finance

Europe’s bellwether challenge

...The other two were British Biotech plc , which infamously imploded in 1998, and Celltech Group plc...
...in 2006 • Lack of internal R&D • Distraction by patent battle with MorphoSys AG Celltech Group plc...
BioCentury | Jul 21, 2016
Strategy

Brexit of brains

...but were taken out via M&A, blunting the growth of the ecosystem. Most notable were Celltech Group plc...
BioCentury | Jun 27, 2016
Finance

Nine lives?

...the funk lasted for at least five years. The next heir to the throne was Celltech Group plc...
BioCentury | Dec 24, 2012
Strategy

The deCoding of Amgen

...bone mineral density was associated with a loss-of-function mutation in the sclerostin gene. In 2002, Celltech Group plc...
BioCentury | Dec 2, 2011
Politics & Policy

EU court ruling clarifies SPCs for combo products

...supporting marketing authorization covered a product with nine ingredients. Medeva was acquired in 2000 by Celltech Group...
BioCentury | Jan 10, 2011
Company News

Symphogen board of directors update

...Symphogen A/S , Copenhagen, Denmark Business: Antibodies Appointed: Goran Ando as chairman, previously CEO of Celltech Group plc...
BioCentury | Jan 7, 2011
Top Story

Symphogen raises EUR 100 million

...also participated. Symphogen also appointed Goran Ando as chairman. Ando is the former CEO of Celltech Group plc...
BioCentury | Dec 20, 2010
Strategy

TAP's Big Finish

...up front from adding additional antigens Up to $1.4B under Aug 2010 amended deal 2002 Celltech Group plc...
BioCentury | Mar 8, 2010
Strategy

Merck's Chemical Test

...UCB started the trend in 2004 when it sold off its chemicals business and acquired Celltech Group plc...
BioCentury | Jan 11, 2010
Strategy

Evolution of Biogen Idec's Pipeline

...CDP 571 humanized anti-TNF alpha mAb Crohn's disease Dropped Partnered by Biogen in 2002 from Celltech Group plc...
Items per page:
1 - 10 of 290